Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-10-21

Clinical Trial Update: Electrocardiographic Mapping and Imaging [EARLY_Phase 1]

View source ↗

Summary

A Mayo Clinic early Phase 1 clinical trial on electrocardiographic mapping and imaging for cardiac arrhythmia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Cardiac Arrhythmia | EARLY_Phase 1 | Status: WITHDRAWN